Clinical Heterogeneity in Autosomal Recessive Bestrophinopathy with Biallelic Mutations in the BEST1 Gene

Autosomal recessive bestrophinopathy (ARB) has been reported as clinically heterogeneous. Eighteen patients (mean age: 22.5 years; 15 unrelated families) underwent ophthalmological examination, fundus photography, fundus autofluorescence, and optical coherence tomography (OCT). Molecular genetic testing of the BEST1 gene was conducted by the chain-terminating dideoxynucleotide Sanger methodology. Onset of symptoms (3 to 50 years of age) and best-corrected visual acuity (0.02–1.0) were highly variable. Ophthalmoscopic and retinal imaging defined five phenotypes. Phenotype I presented with single or confluent yellow lesions at the posterior pole and midperiphery, serous retinal detachment, and intraretinal cystoid spaces. In phenotype II fleck-like lesions were smaller and extended to the far periphery. Phenotype III showed a widespread continuous lesion with sharp peripheral demarcation. Single (phenotype IV) or multifocal (phenotype V) vitelliform macular dystrophy-like lesions were observed as well. Phenotypes varied within families and in two eyes of one patient. In addition, OCT detected hyperreflective foci (13/36 eyes) and choroidal excavation (11/36). Biallelic mutations were identified in each patient, six of which have not been reported so far [c.454C>T/p.(Pro152Ser), c.620T>A/p.(Leu207His), c.287_298del/p.(Gln96_Asn99del), c.199_200del/p.(Leu67Valfs*164), c.524del/p.(Ser175Thrfs*19), c.590_615del/p.(Leu197Profs*26)]. BEST1-associated ARB presents with a variable age of onset and clinical findings, that can be categorized in 5 clinical phenotypes. Hyperreflective foci and choroidal excavation frequently develop as secondary manifestations.

[1]  R. Chawla,et al.  Focal choroidal excavation: review of literature , 2020, British Journal of Ophthalmology.

[2]  C. Nagesha,et al.  Autosomal recessive bestrophinopathy with macular hole , 2020, Indian journal of ophthalmology.

[3]  Rachel L. Taylor,et al.  Small Molecules Restore Bestrophin 1 Expression and Function of Both Dominant and Recessive Bestrophinopathies in Patient-Derived Retinal Pigment Epithelium , 2020, Investigative ophthalmology & visual science.

[4]  S. Halford,et al.  Association of Clinical and Genetic Heterogeneity With BEST1 Sequence Variations. , 2020, JAMA ophthalmology.

[5]  P. Charbel Issa,et al.  Peripapillary Sparing in Autosomal Recessive Bestrophinopathy. , 2020, Ophthalmology. Retina.

[6]  C. Brandl,et al.  [Mutation-Dependent Mechanisms and Their Impact on Targeted Therapeutic Strategies with Reference to Bestrophin 1 and the Bestrophinopathies]. , 2020 .

[7]  C. Brandl,et al.  Mutation-Dependent Pathomechanisms Determine the Phenotype in the Bestrophinopathies , 2020, International journal of molecular sciences.

[8]  G. Casalino,et al.  Autosomal Recessive Bestrophinopathy , 2020, Ophthalmology.

[9]  S. Sadda,et al.  SEROUS MACULAR DETACHMENT IN BEST DISEASE: A Masquerade Syndrome. , 2019, Retina.

[10]  Jian-kang Li,et al.  Mutation spectrum of the bestrophin-1 gene in a large Chinese cohort with bestrophinopathy , 2019, British Journal of Ophthalmology.

[11]  P. Söderkvist,et al.  Novel BEST1 gene mutations associated with two different forms of macular dystrophy in Tunisian families , 2019, Clinical & experimental ophthalmology.

[12]  Mingkai Lin,et al.  Novel BEST1 mutations and special clinical characteristics of autosomal recessive bestrophinopathy in Chinese patients , 2018, Acta ophthalmologica.

[13]  K. Zibara,et al.  Novel Missense Mutations in BEST1 Are Associated with Bestrophinopathies in Lebanese Patients , 2019, Genes.

[14]  Vinod Kumar,et al.  Fibrotic pillar leads to focal choroidal excavation in Best vitelliform dystrophy , 2018, Graefe's Archive for Clinical and Experimental Ophthalmology.

[15]  S. Seshagiri,et al.  Next generation sequencing identifies novel disease-associated BEST1 mutations in Bestrophinopathy patients , 2018, Scientific Reports.

[16]  C. Wetzel,et al.  BEST1 protein stability and degradation pathways differ between autosomal dominant Best disease and autosomal recessive bestrophinopathy accounting for the distinct retinal phenotypes , 2018, Human molecular genetics.

[17]  G. Casalino,et al.  THE EXPANDING CLINICAL SPECTRUM OF CHOROIDAL EXCAVATION IN MACULAR DYSTROPHIES , 2017, Retina.

[18]  Yang Li,et al.  Screening of BEST1 Gene in a Chinese Cohort With Best Vitelliform Macular Dystrophy or Autosomal Recessive Bestrophinopathy. , 2017, Investigative ophthalmology & visual science.

[19]  K. Tsunoda,et al.  Clinical and Genetic Findings of Autosomal Recessive Bestrophinopathy in Japanese Cohort. , 2016, American journal of ophthalmology.

[20]  C. Brandl,et al.  Bestrophin 1 is indispensable for volume regulation in human retinal pigment epithelium cells , 2015, Proceedings of the National Academy of Sciences.

[21]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[22]  Michael Bach,et al.  ISCEV Standard for full-field clinical electroretinography (2015 update) , 2014, Documenta Ophthalmologica.

[23]  You-xin Chen,et al.  Screening for BEST1 gene mutations in Chinese patients with bestrophinopathy , 2014, Molecular vision.

[24]  F. Riemslag,et al.  Autosomal recessive bestrophinopathy: differential diagnosis and treatment options. , 2013, Ophthalmology.

[25]  S. Wolf,et al.  Behavior of SD-OCT-detected hyperreflective foci in the retina of anti-VEGF-treated patients with diabetic macular edema. , 2012, Investigative ophthalmology & visual science.

[26]  H. Jägle,et al.  Gyrate atrophy: clinical and genetic findings in a female without arginine-restricted diet during her first 39 years of life and report of a new OAT gene mutation , 2012, Documenta Ophthalmologica.

[27]  G. Querques,et al.  Unilateral Vitelliform Phenotype in Autosomal Recessive Bestrophinopathy , 2012, Ophthalmic Research.

[28]  Donald C. Hood,et al.  ISCEV standard for clinical multifocal electroretinography (mfERG) (2011 edition) , 2012, Documenta Ophthalmologica.

[29]  Michael Bach,et al.  ISCEV standard for clinical electro-oculography (2010 update) , 2011, Documenta Ophthalmologica.

[30]  S. Wolf,et al.  Small dense particles in the retina observable by spectral-domain optical coherence tomography in age-related macular degeneration. , 2010, Investigative ophthalmology & visual science.

[31]  S. Jacobson,et al.  Missense mutations in a retinal pigment epithelium protein, bestrophin-1, cause retinitis pigmentosa. , 2009, American journal of human genetics.

[32]  B. J. Klevering,et al.  The spectrum of ocular phenotypes caused by mutations in the BEST1 gene , 2009, Progress in Retinal and Eye Research.

[33]  H. C. Hartzell,et al.  Molecular physiology of bestrophins: multifunctional membrane proteins linked to best disease and other retinopathies. , 2008, Physiological reviews.

[34]  G. Holder,et al.  Biallelic mutation of BEST1 causes a distinct retinopathy in humans. , 2008, American journal of human genetics.

[35]  A. Marmorstein,et al.  Focus on molecules: bestrophin (best-1). , 2007, Experimental eye research.

[36]  G. Holder,et al.  Evidence of genetic heterogeneity in MRCS (microcornea, rod-cone dystrophy, cataract, and posterior staphyloma) syndrome. , 2006, American journal of ophthalmology.

[37]  N. Dahl,et al.  Variant Phenotype of Best Vitelliform Macular Dystrophy Associated with Compound Heterozygous Mutations in VMD2 , 2006, Ophthalmic genetics.

[38]  B. Wissinger,et al.  MORPHOLOGY AND FUNCTIONAL CHARACTERISTICS IN ADULT VITELLIFORM MACULAR DYSTROPHY , 2004, Retina.

[39]  D. Baralle,et al.  Mutations of VMD2 splicing regulators cause nanophthalmos and autosomal dominant vitreoretinochoroidopathy (ADVIRC). , 2004, Investigative ophthalmology & visual science.

[40]  J. Nathans,et al.  The vitelliform macular dystrophy protein defines a new family of chloride channels , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[41]  B. Lorenz,et al.  Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) and adult vitelliform macular dystrophy but not age-related macular degeneration , 2000, European Journal of Human Genetics.

[42]  H. Stöhr,et al.  Mutations in a novel gene, VMD2, encoding a protein of unknown properties cause juvenile-onset vitelliform macular dystrophy (Best's disease). , 1998, Human molecular genetics.

[43]  M. Metzker,et al.  Identification of the gene responsible for Best macular dystrophy , 1998, Nature Genetics.